DCMM
DG Capital Management (Massachusetts) Portfolio holdings
AUM
$102M
This Quarter Return
+5.67%
1 Year Return
+29.14%
3 Year Return
+96.76%
5 Year Return
–
10 Year Return
–
AUM
$166M
AUM Growth
+$166M
(-0.07%)
Cap. Flow
-$6.91M
Cap. Flow
% of AUM
-4.16%
Top 10 Holdings %
Top 10 Hldgs %
29.78%
Holding
76
New
12
Increased
23
Reduced
29
Closed
11
Top Buys
| 1 |
BioMarin Pharmaceuticals
BMRN
|
$3.33M |
| 2 |
Ulta Beauty
ULTA
|
$2.22M |
| 3 |
Canadian Solar
CSIQ
|
$2.12M |
| 4 |
Bristol-Myers Squibb
BMY
|
$1.62M |
| 5 |
AbbVie
ABBV
|
$1.51M |
Top Sells
| 1 |
Chubb
CB
|
$2.79M |
| 2 |
Texas Instruments
TXN
|
$2.45M |
| 3 |
Amgen
AMGN
|
$2.32M |
| 4 |
HAR
Harman International Industries
HAR
|
$2.32M |
| 5 |
Tyson Foods
TSN
|
$1.89M |
Sector Composition
| 1 | Healthcare | 39.3% |
| 2 | Financials | 15.77% |
| 3 | Technology | 11.18% |
| 4 | Communication Services | 8.59% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Biogen
BIIB
$20.5B
| $8.03M | 4.84% |
19,874
+2,090
| +12% | +$844K |
|
2
Eli Lilly
LLY
$659B
| $6.47M | 3.9% |
77,435
-1,660
| -2% | -$139K |
|
3
Visa
V
$679B
| $4.74M | 2.86% |
70,655
+7,495
| +12% | +$503K |
|
|
4
Amgen
AMGN
$154B
| $4.65M | 2.8% |
30,285
-15,108
| -33% | -$2.32M |
|
5
Gilead Sciences
GILD
$140B
| $4.5M | 2.71% |
38,400
+1,075
| +3% | +$126K |
|
|
6
Bristol-Myers Squibb
BMY
$96.5B
| $4.25M | 2.56% |
63,905
+24,330
| +61% | +$1.62M |
|
7
Mastercard
MA
$535B
| $4.24M | 2.55% |
45,345
+3,575
| +9% | +$334K |
|
8
HCA Healthcare
HCA
$95B
| $4.21M | 2.54% |
46,423
+7,880
| +20% | +$715K |
|
|
9
AbbVie
ABBV
$374B
| $4.21M | 2.54% |
62,650
+22,435
| +56% | +$1.51M |
|
10
Nike
NKE
$110B
| $4.13M | 2.49% |
38,271
-330
| -0.9% | -$35.6K |
|
11
Novartis
NVS
$245B
| $4.04M | 2.43% |
41,075
-2,175
| -5% | -$214K |
|
12
Adobe
ADBE
$147B
| $3.88M | 2.34% |
47,939
-9,665
| -17% | -$783K |
|
13
Apple
AAPL
$3.41T
| $3.78M | 2.28% |
30,130
-720
| -2% | -$90.3K |
|
14
Goldman Sachs
GS
$221B
| $3.77M | 2.27% |
18,065
+305
| +2% | +$63.7K |
|
15
FedEx
FDX
$52.9B
| $3.65M | 2.2% |
21,415
-3,975
| -16% | -$677K |
|
|
16
BioMarin Pharmaceuticals
BMRN
$11.3B
| $3.33M | 2.01% |
+24,345
| New | +$3.33M |
|
|
AGN
17
DELISTED
Allergan plc
AGN
| $3.3M | 1.99% |
10,888
+90
| +0.8% | +$27.3K |
|
|
TWX
18
DELISTED
Time Warner Inc
TWX
| $3.29M | 1.98% |
37,625
-680
| -2% | -$59.4K |
|
|
RCPT
19
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $3.28M | 1.98% |
17,255
+5,890
| +52% | +$1.12M |
|
20
Netflix
NFLX
$516B
| $3.27M | 1.97% |
4,970
-1,375
| -22% | -$903K |
|
21
American Airlines Group
AAL
$8.84B
| $3.08M | 1.86% |
77,094
-11,958
| -13% | -$478K |
|
|
AET
22
DELISTED
Aetna Inc
AET
| $2.87M | 1.73% |
22,542
+465
| +2% | +$59.3K |
|
23
Meta Platforms (Facebook)
META
$1.85T
| $2.87M | 1.73% |
33,478
-6,675
| -17% | -$572K |
|
|
MJN
24
DELISTED
Mead Johnson Nutrition Company
MJN
| $2.83M | 1.71% |
31,370
-8,670
| -22% | -$782K |
|
25
Bausch Health
BHC
$2.84B
| $2.8M | 1.69% |
12,620
+2,290
| +22% | +$509K |
|